# Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention

> **NCT01878669** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Suleyman Demirel University** · enrollment: 390 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** N-acetyl cysteine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01878669
- **Lead sponsor:** Suleyman Demirel University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-01
- **Primary completion:** 2017-09
- **Final completion:** 2026-12
- **Target enrollment:** 390 (ESTIMATED)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01878669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01878669, "Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01878669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*